Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 18, 2015
The impact of portal pedicle clamping on survival from colorectal liver metastases in the contemporary era of liver resection: a matched cohort studyMelanie E Tsang, Paul J Karanicolas, Rogeh Habashi, et al.Developmental Cell|January 18, 2003
Conserved requirement of Lim1 function for cell movements during gastrulationNeil A Hukriede, Tania E Tsang, Raymond Habas, et al.Chemical Communications (Cambridge, England)|June 29, 2017
Niobate nanosheet membranes with enhanced stability for nanofiltrationK Nakagawa, H Yamashita, D Saeki, et al.Diabetologia|December 3, 2011
Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled studyC Beysen, E J Murphy, K Deines, et al.Infection and Immunity|February 17, 2001
Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathologyV P Mohan, C A Scanga, K Yu, et al.Journal of Surgical Oncology|September 10, 2018
Assessing tools for management of noncolorectal nonneuroendocrine liver metastases: External validation of a prognostic modelMelanie E Tsang, Alyson L Mahar, Guillaume Martel, et al.Chemical Communications (Cambridge, England)|September 25, 2014
Dual doping effects (site blockage and electronic promotion) imposed by adatoms on Pd nanocrystals for catalytic hydrogen productionS Jones, S M Fairclough, M Gordon-Brown, et al.Developmental Biology|June 23, 2000
Lim1 activity is required for intermediate mesoderm differentiation in the mouse embryoT E Tsang, W Shawlot, S J Kinder, et al.Journal of Surgical Oncology|February 9, 2020
Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trialPablo E Serrano, Chu-Shu Gu, Carol-Anne Moulton, et al.ACS Medicinal Chemistry Letters|October 16, 2020
Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain TumorsJonathan E Tsang, Lorenz M Urner, Gyudong Kim, et al.Pageof 5